Physician profile
Dan L Stewart
NPI 1386629871
$255,875.27
in general payments reported to CMS, 2019-2025
13 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $24K · 2021: $12K · 2022: $53K · 2023: $20K · 2024: $56K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Consulting Fee: $18K · Travel and Lodging: $13K · Honoraria: $11K · Food and Beverage: $1,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71,665.00 |
| Consulting Fee | $17,520.00 |
| Travel and Lodging | $13,381.42 |
| Honoraria | $11,400.00 |
| Food and Beverage | $1,570.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $81,318.88 | 2020-2025 | Inomax |
| Chiesi USA, INC. | $59,596.25 | 2019-2025 | Curosurf |
| Sobi, INC | $50,072.16 | 2019-2021 | |
| Sanofi Pasteur INC. | $45,865.02 | 2022-2025 | |
| Mallinckrodt Enterprises LLC | $17,366.37 | 2019 | |
| Covidien Lp | $976.22 | 2019 | |
| Medtronic, INC. | $310.91 | 2022 | |
| Abiomed | $138.48 | 2022 | |
| Boston Scientific Corporation | $110.56 | 2020 | |
| Stryker Corporation | $59.51 | 2020 | |
| Shockwave Medical, INC | $32.02 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $28.89 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.